TeraImmune

Gaithersburg, United States

TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.

$3.0M raised

Dec 2022

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TeraImmune raised?

TeraImmune has raised $3.0M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2022.

Who are TeraImmune's investors?

TeraImmune's investors include Shinhan Venture Investment.

Where is TeraImmune headquartered?

TeraImmune is headquartered in Gaithersburg, United States.

What does TeraImmune do?

TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.

What stage is TeraImmune at?

TeraImmune is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 22, 2022.

MLA

"TeraImmune — Funding & Investors." VCBacked, December 22, 2022, https://www.vcbacked.co/company/teraimmune. Accessed July 2, 2026.

APA

VCBacked. (2022). TeraImmune — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/teraimmune

Wikipedia (cite web)

{{cite web |title=TeraImmune — Funding & Investors |url=https://www.vcbacked.co/company/teraimmune |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 22, 2022.